Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Muzahir H. Tayebjee, Sunil Nadar, Andrew D. Blann, D. Gareth Beevers, Robert J. MacFadyen, Gregory Y.H. Lip

Research output: Contribution to journal › Article › peer-review

129 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry